vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and iQSTEL Inc (IQST). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). iQSTEL Inc runs the higher net margin — -3.2% vs -70.9%, a 67.7% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -14.9%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-1.8M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
CTKB vs IQST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $84.2M |
| Net Profit | $-44.1M | $-2.7M |
| Gross Margin | 52.9% | 3.5% |
| Operating Margin | -9.0% | -2.9% |
| Net Margin | -70.9% | -3.2% |
| Revenue YoY | 8.1% | -14.9% |
| Net Profit YoY | -557.1% | -44.5% |
| EPS (diluted) | — | $-0.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $84.2M | ||
| Q3 25 | $52.3M | $102.9M | ||
| Q2 25 | $45.6M | $72.2M | ||
| Q1 25 | $41.5M | $57.6M | ||
| Q4 24 | $57.5M | $98.9M | ||
| Q3 24 | $51.5M | $54.2M | ||
| Q2 24 | $46.6M | $78.6M | ||
| Q1 24 | $44.9M | $51.4M |
| Q4 25 | $-44.1M | $-2.7M | ||
| Q3 25 | $-5.5M | $-2.3M | ||
| Q2 25 | $-5.6M | $-2.3M | ||
| Q1 25 | $-11.4M | $-1.1M | ||
| Q4 24 | $9.6M | $-1.9M | ||
| Q3 24 | $941.0K | $-773.0K | ||
| Q2 24 | $-10.4M | $-2.0M | ||
| Q1 24 | $-6.2M | $-580.2K |
| Q4 25 | 52.9% | 3.5% | ||
| Q3 25 | 52.7% | 2.7% | ||
| Q2 25 | 52.3% | 2.6% | ||
| Q1 25 | 48.6% | 3.4% | ||
| Q4 24 | 58.5% | 2.7% | ||
| Q3 24 | 56.3% | 3.7% | ||
| Q2 24 | 54.6% | 2.8% | ||
| Q1 24 | 51.3% | 2.7% |
| Q4 25 | -9.0% | -2.9% | ||
| Q3 25 | -17.6% | -0.5% | ||
| Q2 25 | -23.3% | -0.9% | ||
| Q1 25 | -36.1% | -1.0% | ||
| Q4 24 | 5.2% | -0.3% | ||
| Q3 24 | -8.2% | -0.1% | ||
| Q2 24 | -18.3% | -0.4% | ||
| Q1 24 | -23.9% | -0.4% |
| Q4 25 | -70.9% | -3.2% | ||
| Q3 25 | -10.5% | -2.3% | ||
| Q2 25 | -12.2% | -3.3% | ||
| Q1 25 | -27.5% | -2.0% | ||
| Q4 24 | 16.8% | -1.9% | ||
| Q3 24 | 1.8% | -1.4% | ||
| Q2 24 | -22.4% | -2.5% | ||
| Q1 24 | -13.8% | -1.1% |
| Q4 25 | — | $-0.92 | ||
| Q3 25 | — | $-0.68 | ||
| Q2 25 | — | $-0.82 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $-1.19 | ||
| Q3 24 | — | $-0.40 | ||
| Q2 24 | — | $-0.90 | ||
| Q1 24 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $2.2M |
| Total DebtLower is stronger | — | $4.1M |
| Stockholders' EquityBook value | $341.7M | $16.3M |
| Total Assets | $461.5M | $51.1M |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $2.2M | ||
| Q3 25 | $93.3M | $2.3M | ||
| Q2 25 | $75.5M | $2.0M | ||
| Q1 25 | $95.3M | $1.1M | ||
| Q4 24 | $98.7M | $2.5M | ||
| Q3 24 | $162.3M | $2.1M | ||
| Q2 24 | $177.9M | $797.2K | ||
| Q1 24 | $168.8M | $2.7M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $3.5M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $194.0K |
| Q4 25 | $341.7M | $16.3M | ||
| Q3 25 | $378.6M | $17.9M | ||
| Q2 25 | $377.6M | $14.3M | ||
| Q1 25 | $379.6M | $11.6M | ||
| Q4 24 | $395.7M | $11.9M | ||
| Q3 24 | $385.5M | $8.1M | ||
| Q2 24 | $389.1M | $7.6M | ||
| Q1 24 | $392.6M | $8.4M |
| Q4 25 | $461.5M | $51.1M | ||
| Q3 25 | $494.9M | $46.9M | ||
| Q2 25 | $493.3M | $51.4M | ||
| Q1 25 | $482.6M | $42.0M | ||
| Q4 24 | $499.5M | $79.0M | ||
| Q3 24 | $491.2M | $32.4M | ||
| Q2 24 | $483.7M | $30.0M | ||
| Q1 24 | $492.1M | $22.1M |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-1.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $-1.2M |
| FCF MarginFCF / Revenue | -2.9% | -1.5% |
| Capex IntensityCapex / Revenue | 1.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-4.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-1.2M | ||
| Q3 25 | $-3.9M | $-953.0K | ||
| Q2 25 | $108.0K | $257.7K | ||
| Q1 25 | $-125.0K | $-1.9M | ||
| Q4 24 | $2.0M | $-403.7K | ||
| Q3 24 | $13.2M | $625.0K | ||
| Q2 24 | $6.2M | $-2.6M | ||
| Q1 24 | $4.0M | $-536.9K |
| Q4 25 | $-1.8M | $-1.2M | ||
| Q3 25 | $-4.6M | $-969.2K | ||
| Q2 25 | $-1.5M | $211.7K | ||
| Q1 25 | $-974.0K | $-2.0M | ||
| Q4 24 | $1.1M | $-421.3K | ||
| Q3 24 | $12.2M | $594.5K | ||
| Q2 24 | $5.2M | $-2.6M | ||
| Q1 24 | $3.4M | $-608.5K |
| Q4 25 | -2.9% | -1.5% | ||
| Q3 25 | -8.7% | -0.9% | ||
| Q2 25 | -3.2% | 0.3% | ||
| Q1 25 | -2.3% | -3.4% | ||
| Q4 24 | 1.9% | -0.4% | ||
| Q3 24 | 23.7% | 1.1% | ||
| Q2 24 | 11.0% | -3.4% | ||
| Q1 24 | 7.6% | -1.2% |
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.0% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
